Results 221 to 230 of about 846,625 (333)

Nanoformulated Diacerein Alleviates Hyperlipidemia via Gut Microbiota Modulation In Vivo

open access: yesNano Select, EarlyView.
A nanoformulation of diacerein (Nano‐DIA) was fabricated with carboxymethyl cellulose, achieving enhanced solubility and rapid dissolution for alternative anti‐hyperlipidemia therapeutics. Mechanistic studies revealed its in vivo lipid‐lowering efficacy is through metabolite‐mediated and microbiota‐dependent manner, highlighting its dual action on host
Zheng Peng   +8 more
wiley   +1 more source

Personalized Differential Privacy for Ridge Regression Under Output Perturbation

open access: yesNaval Research Logistics (NRL), EarlyView.
ABSTRACT The increased application of machine learning (ML) in sensitive domains requires protecting the training data through privacy frameworks, such as differential privacy (DP). Traditional DP enforces a uniform privacy level ε$$ \varepsilon $$, which bounds the maximum privacy loss that each data point in the dataset is allowed to incur.
Krishna Acharya   +3 more
wiley   +1 more source

Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
Liver cancer remains a leading global health threat, imposing a substantial and growing burden of disease and disability. This study explores the epidemiologic landscape of liver cancer worldwide and within China over recent decade using Global Burden of Disease database 2021 study.
Jiaqi Ruan, Hangkai Huang, Chengfu Xu
wiley   +1 more source

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

open access: yesRheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy